He said that in order to move towards developing vaccines for Kovid-19, Chikungunya, Zika, Cholera and other infections, it is necessary to recover the cost of this vaccine. The company has set its price in the market for export between 15 and 20 dollars.
New Delhi. ‘Bharat BiotechThe company said on Saturday that it COVID-19 Vaccines’Covaxine‘Will provide Rs 600 per dose to state governments and Rs 1,200 per dose to private hospitals. Krishna M Alla, the chairman and managing director of this Hyderabad-based company, said that his company Central government Is supplying covaxine at the rate of Rs 150 per dose. “We want to inform that more than half the production capacity of the company has been reserved for supply to the central government,” Alla said, adding that vaccines for Kovid-19, chikungunya, zika, cholera and other infections In order to move forward in the direction of development, it is necessary that the cost of this vaccine is realized. The company has set its price in the market for export between 15 and 20 dollars.
Earlier, the Serum Institute of India (SII) had announced its Kovid-19 vaccine Kovishield at a rate of Rs 400 per dose to state governments and Rs 600 per dose to private hospitals. SII had also said that it would solve the problem of limited capacity by increasing vaccine production in the next two months. Serum Institute of India said in a statement, “50 percent of our capacity will be for the Indian government’s immunization program and the remaining 50 percent will be for state governments and private hospitals.” Rs 1,500 per dose while vaccines in Russia and China cost more than Rs 750 per dose. According to government data released on Wednesday, 90 per cent of the 12.76 million vaccines of Kovid-19 in the country so far have been applied to Kovishield of Oxford / AstraZeneca.
Disclaimer:Prabhasakshi has not edited this news. This news has been published from PTI-language feed.
note:We are fully participants in India’s fight against the Corona virus. In this difficult time, it is our every effort to fully publish our responsibilities that only news based on facts should be published. We are also in self-discipline and following all the rules issued by the government is also our first priority.